Lanospharma Laboratories Co.,Ltd

Low cost of Active pharmaceutical ingredients and intermediates
语言/Language: 中文/English
Compounds
Vitamin D4,97.0%-103.0%
Vitamin D4,511-28-4
(R)-BoroLeu-(+)-Pinanediol-CF3COOH [HOT] [Intermediate]
AA008:(2S,3R)-2-amino-3-hydroxy-succinic acid,6532-76-9,98%
COA of AA008,(2S,3R)-2-amino-3-hydroxy-succinic acid,6532-76-9,>98%
[Catalogue No.
]:
AA008
[Product Name
]:
(2S,3R)-2-amino-3-hydroxy-succinic acid
[CAS
]:
6532-76-9
[Molecular formula
]:
[Quality
]:
98%
[Specturm
]:
H-NMR;HPLC spectrum
[Quantity
]:
10g;100g;1000g
 
 
[Certificate of Analysis
]:
 
[MSDS
]:
Mr.Wen Meijaing info@lanospharma.com
 
[Price
]:
 
[Stock status
]:
[1]Stock compound will be delivered within 3 days; [2]The H-NMR and HPLC specturm (or other necessary test specturms) of custom synthesis compound will be sent for your approval proir to shippment.[3]Controlled compound and Patented compound are not available.[4] You can also send an inquiry and order via online order or to info@lanospharma.com
 
Cooperation
During the last 9 years,we have established a good cooperation with the famous Research Institutes,Chemical and pharmaceutical companies all over the world.
2008-
Applichem
Germany
2009-
Brookwoodpharma
USA
2010-
Formosalab
Taiwan
2011-
Sanofi-Aventis
Czech republic
2012-
Abcam
UK
2012-
Chemimpex
USA
2013-
Stanford University
USA
2013-
Topchem
Ireland
2014-
Neuland Pharma Research
India
2014-
LeeChem Co.,Ltd
Korea
2015-
Chemos
Germany
2015-
Novartis
China
2016-
Henkel Corporation
USA
 
Contact us for more information
Chemical information
Compound Name*
CAS No. "N/A" if the CAS not available*
Quantity*
 
Contact information
Contact person*
Email Address *
Tel No.*
Company or Organization Name*
Shipping Address*
Country
Remarks

<Privacy policy: the contact information will be only used for this business contact>

Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.
PD4
the buyer assumes responsibility of all patent considerations in the use of (2S,3R)-2-amino-3-hydroxy-succinic acid,6532-76-9.
我要啦免费统计